ono 1078 has been researched along with Brain Swelling in 5 studies
pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats." | 7.72 | [Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats]. ( Chen, Z; Wei, EQ; Zhang, SF; Zhang, SH; Zhu, CY, 2004) |
| "Montelukast was injected intraperitoneally either as multiple doses (once a day for 3 days and 30 min before MCAO) or as a single dose (at 30 min before, 30 min after, or 1 h after MCAO), respectively, and pranlukast and edaravone were used as controls." | 5.33 | Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. ( Chen, Z; Chu, LS; Mei, RH; Wei, EQ; Xu, HM; Yu, GL; Zhang, Q; Zhang, SH; Zhang, WP; Zhao, MH, 2005) |
| "To determine the protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats." | 3.72 | [Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats]. ( Chen, Z; Wei, EQ; Zhang, SF; Zhang, SH; Zhu, CY, 2004) |
| "Montelukast was injected intraperitoneally either as multiple doses (once a day for 3 days and 30 min before MCAO) or as a single dose (at 30 min before, 30 min after, or 1 h after MCAO), respectively, and pranlukast and edaravone were used as controls." | 1.33 | Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice. ( Chen, Z; Chu, LS; Mei, RH; Wei, EQ; Xu, HM; Yu, GL; Zhang, Q; Zhang, SH; Zhang, WP; Zhao, MH, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shi, QJ | 1 |
| Wang, H | 1 |
| Liu, ZX | 1 |
| Fang, SH | 1 |
| Song, XM | 1 |
| Lu, YB | 1 |
| Zhang, WP | 4 |
| Sa, XY | 1 |
| Ying, HZ | 1 |
| Wei, EQ | 5 |
| Mei, RH | 2 |
| Zhu, CY | 2 |
| Zhao, MH | 2 |
| Zhang, SH | 2 |
| Chen, Z | 3 |
| Zhang, SF | 1 |
| Yu, GL | 1 |
| Xu, HM | 1 |
| Chu, LS | 1 |
| Zhang, Q | 1 |
| Qian, XD | 1 |
| Zhang, L | 1 |
| Sheng, WW | 1 |
| Wang, ML | 1 |
5 other studies available for ono 1078 and Brain Swelling
| Article | Year |
|---|---|
HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Topics: Acute Disease; Animals; Brain; Brain Edema; Brain Ischemia; Chromones; Cyclohexanecarboxylic Acids; | 2015 |
Neuroprotective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia in rats.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Chromones; Infarction, Middle Cerebral Artery; Leukotrien | 2002 |
[Protective effect of ONO-1078, a leukotriene receptor antagonist, on focal cerebral ischemia induced by endothelin-1 in rats].
Topics: Animals; Behavior, Animal; Brain Edema; Brain Ischemia; Cerebral Cortex; Cerebral Infarction; Chromo | 2004 |
Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Topics: Acetates; Animals; Antipyrine; Blood-Brain Barrier; Brain; Brain Edema; Brain Ischemia; Chromones; C | 2005 |
Pranlukast, a cysteinyl leukotriene receptor 1 antagonist, protects mice against brain cold injury.
Topics: Animals; Brain; Brain Edema; Brain Injuries; Cell Count; Chromones; Cold Temperature; Dose-Response | 2006 |